Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $73000.0.

  • Rapid Micro Biosystems' Capital Expenditures fell 6726.46% to $73000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $856000.0, marking a year-over-year decrease of 4919.88%. This contributed to the annual value of $1.4 million for FY2024, which is 2601.63% down from last year.
  • Rapid Micro Biosystems' Capital Expenditures amounted to $73000.0 in Q3 2025, which was down 6726.46% from $366000.0 recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Capital Expenditures registered a high of $2.4 million during Q1 2022, and its lowest value of $73000.0 during Q3 2025.
  • Its 5-year average for Capital Expenditures is $732894.7, with a median of $459000.0 in 2021.
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 148548.39% in 2021, then crashed by 8919.05% in 2023.
  • Over the past 5 years, Rapid Micro Biosystems' Capital Expenditures (Quarter) stood at $2.0 million in 2021, then crashed by 58.75% to $811000.0 in 2022, then tumbled by 48.46% to $418000.0 in 2023, then tumbled by 76.56% to $98000.0 in 2024, then decreased by 25.51% to $73000.0 in 2025.
  • Its Capital Expenditures stands at $73000.0 for Q3 2025, versus $366000.0 for Q2 2025 and $319000.0 for Q1 2025.